BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37419986)

  • 21. Perturbed Brain Glucose Metabolism Caused by Absent SIRT3 Activity.
    Kristian T; Karimi AJ; Fearnow A; Waddell J; McKenna MC
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.
    Hirschey MD; Shimazu T; Goetzman E; Jing E; Schwer B; Lombard DB; Grueter CA; Harris C; Biddinger S; Ilkayeva OR; Stevens RD; Li Y; Saha AK; Ruderman NB; Bain JR; Newgard CB; Farese RV; Alt FW; Kahn CR; Verdin E
    Nature; 2010 Mar; 464(7285):121-5. PubMed ID: 20203611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target.
    Zhang J; Xiang H; Liu J; Chen Y; He RR; Liu B
    Theranostics; 2020; 10(18):8315-8342. PubMed ID: 32724473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disorders.
    Mishra Y; Kaundal RK
    Drug Discov Today; 2023 Jun; 28(6):103583. PubMed ID: 37028501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maestro of the SereNADe: SLC25A51 Orchestrates Mitochondrial NAD
    Ouyang Y; Bott AJ; Rutter J
    Trends Biochem Sci; 2021 May; 46(5):348-350. PubMed ID: 33618948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous H
    Sun Y; Teng Z; Sun X; Zhang L; Chen J; Wang B; Lu F; Liu N; Yu M; Peng S; Wang Y; Zhao D; Zhao Y; Ren H; Cheng Z; Dong S; Lu F; Zhang W
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E284-E297. PubMed ID: 31184932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAD
    Klimova N; Fearnow A; Long A; Kristian T
    Exp Neurol; 2020 Mar; 325():113144. PubMed ID: 31837320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
    Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
    Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial Sirtuin 3 and Renal Diseases.
    Perico L; Morigi M; Benigni A
    Nephron; 2016; 134(1):14-9. PubMed ID: 27362524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Friedreich's ataxia reveals a mechanism for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3 deacetylase.
    Wagner GR; Pride PM; Babbey CM; Payne RM
    Hum Mol Genet; 2012 Jun; 21(12):2688-97. PubMed ID: 22394676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism.
    Wang T; Cao Y; Zheng Q; Tu J; Zhou W; He J; Zhong J; Chen Y; Wang J; Cai R; Zuo Y; Wei B; Fan Q; Yang J; Wu Y; Yi J; Li D; Liu M; Wang C; Zhou A; Li Y; Wu X; Yang W; Chin YE; Chen G; Cheng J
    Mol Cell; 2019 Aug; 75(4):823-834.e5. PubMed ID: 31302001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells.
    Cui Y; Qin L; Wu J; Qu X; Hou C; Sun W; Li S; Vaughan AT; Li JJ; Liu J
    PLoS One; 2015; 10(6):e0129834. PubMed ID: 26121691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and Characterization of Sirtuin3 (SIRT3).
    Man AW; Bai B; Wang Y
    Methods Mol Biol; 2016; 1436():201-11. PubMed ID: 27246217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions.
    Kim TS; Jin YB; Kim YS; Kim S; Kim JK; Lee HM; Suh HW; Choe JH; Kim YJ; Koo BS; Kim HN; Jung M; Lee SH; Kim DK; Chung C; Son JW; Min JJ; Kim JM; Deng CX; Kim HS; Lee SR; Jo EK
    Autophagy; 2019 Aug; 15(8):1356-1375. PubMed ID: 30774023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirtuin 3: Emerging therapeutic target for cardiovascular diseases.
    Cao M; Zhao Q; Sun X; Qian H; Lyu S; Chen R; Xia H; Yuan W
    Free Radic Biol Med; 2022 Feb; 180():63-74. PubMed ID: 35031448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
    Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
    PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis.
    Fernandez-Marcos PJ; Jeninga EH; Canto C; Harach T; de Boer VC; Andreux P; Moullan N; Pirinen E; Yamamoto H; Houten SM; Schoonjans K; Auwerx J
    Sci Rep; 2012; 2():425. PubMed ID: 22645641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuin 3 silencing improves oxaliplatin efficacy through acetylation of MnSOD in colon cancer.
    Torrens-Mas M; Hernández-López R; Oliver J; Roca P; Sastre-Serra J
    J Cell Physiol; 2018 Aug; 233(8):6067-6076. PubMed ID: 29323702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Lysine Acetylation: Grease or Sand in the Gears of β-Cell Mitochondria?
    Santo-Domingo J; Dayon L; Wiederkehr A
    J Mol Biol; 2020 Mar; 432(5):1446-1460. PubMed ID: 31628953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in characterization of SIRT3 deacetylation targets in mitochondrial function.
    Wang S; Zhang J; Deng X; Zhao Y; Xu K
    Biochimie; 2020 Dec; 179():1-13. PubMed ID: 32898647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.